top of page
From the Gregor Desk


The Silent Profit Killer: Why Unchecked Expiry is Crippling Your Commercial Health
The pharmaceutical industry operates on razor-thin margins and tight regulatory requirements, yet one silent, persistent cost continues to erode profitability: product expiry . This is more than just a supply chain headache; it's a critical commercial failure that speaks to a profound disconnect between market demand and operational planning. In a data-rich era, high expiry rates are no longer an acceptable cost of doing business—they are a direct indicator that your commerci
Dr. Rajashri Mokashi
Dec 13 min read
Â
Â
Â


The ROI of Accuracy: How Precision Targeting Transforms Incentives and Sales Growth
For the Commercial Excellence  team, the field force is your most valuable asset and your largest variable cost. Historically, sales force deployment has been an exercise in estimation, relying heavily on legacy hierarchies and historical sales rather than true future potential. In today’s hyper-competitive and data-rich healthcare environment—where Organized Trade dictates fulfillment and micro-market dynamics change monthly—this approach is no longer sustainable. It is a fu
Dr. Rajashri Mokashi
Nov 174 min read
Â
Â
Â


From Push to Pull: Mastering Commercial Analytics in the Era of Organized Trade
The landscape of healthcare commerce has fundamentally shifted. For years, the core mission of Commercial Excellence  was centered on Demand Generation —driving the prescription through effective engagement with Healthcare Professionals (HCPs). Today, the rapid ascent of Organized Trade (OT) , including major pharmacy chains and e-commerce platforms like MedPlus, has introduced a far more complex challenge: the imperative of precise Demand Fulfillment . Success is no longer g
Dr. Rajashri Mokashi
Nov 43 min read
Â
Â
Â


Supply Chain Analytics in Crisis Mode: Building Resilience Beyond the Spreadsheet
The phone call comes at 7 AM on a Tuesday. Your largest manufacturing facility in India has just been hit by unexpected flooding....
Dr. Rajashri Mokashi
Sep 155 min read
Â
Â
Â


Building for Real Impact: The Responsibility of AI in Pharma Analytics
The pharmaceutical industry stands at a pivotal moment. With AI spending projected to reach $16.49 billion by 2034, we're witnessing...
Dr. Rajashri Mokashi
Sep 16 min read
Â
Â
Â


What Gregor Analytics Offers: A Clearer Path to Healthcare Decision-Making
What Gregor Analytics Offers: A Clearer Path to Healthcare Decision-Making
Dr. Rajashri Mokashi
Aug 184 min read
Â
Â
Â


AI in Healthcare Analytics: Progress or Premature Hype?
Artificial Intelligence (AI) has become one of the most talked-about developments in healthcare and pharmaceutical analytics . It...
Dr. Rajashri Mokashi
Aug 14 min read
Â
Â
Â


Introducing Gregor Analytics: Clarity in a World of Confusing Data
In today’s healthcare and pharmaceutical landscape, data is everywhere. Every click, every visit, every transaction leaves a trail. But...
Dr. Rajashri Mokashi
Jul 283 min read
Â
Â
Â
bottom of page
